Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Aluminum hydroxide (in vaccine) |
Is a |
False |
Aluminium hydroxide |
Inferred relationship |
Some |
|
Accidental aluminum hydroxide poisoning |
Causative agent (attribute) |
False |
Aluminium hydroxide |
Inferred relationship |
Some |
|
Intentional aluminium hydroxide poisoning |
Causative agent (attribute) |
False |
Aluminium hydroxide |
Inferred relationship |
Some |
|
Aluminum hydroxide poisoning of undetermined intent |
Causative agent (attribute) |
False |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Aluminum hydroxide adverse reaction |
Causative agent (attribute) |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Aluminum hydroxide overdose |
Causative agent (attribute) |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Accidental aluminium hydroxide overdose |
Causative agent (attribute) |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Intentional aluminum hydroxide overdose |
Causative agent (attribute) |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Aluminum hydroxide overdose of undetermined intent |
Causative agent (attribute) |
False |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Aluminum hydroxide [antacid] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium hydroxide |
Inferred relationship |
Some |
|
Aluminium hydroxide 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium hydroxide |
Inferred relationship |
Some |
|
Aluminum hydroxide oral suspension BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium hydroxide |
Inferred relationship |
Some |
|
Product containing precisely aluminium hydroxide 475 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium hydroxide |
Inferred relationship |
Some |
|
Poisoning by aluminum hydroxide |
Causative agent (attribute) |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Aluminum hydroxide [nutritional use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium hydroxide |
Inferred relationship |
Some |
|
Product containing aluminium hydroxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Aluminum hydroxide+belladonna mixture |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium hydroxide |
Inferred relationship |
Some |
|
Aluminum hydroxide+belladonna |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium hydroxide |
Inferred relationship |
Some |
|
Product containing aluminium hydroxide and magnesium carbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Product containing alginic acid and aluminium hydroxide and magnesium trisilicate and sodium bicarbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Product containing aluminium hydroxide and magnesium hydroxide and simeticone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Accidental aluminum hydroxide poisoning |
Causative agent (attribute) |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Intentional aluminium hydroxide poisoning |
Causative agent (attribute) |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Allergy to aluminium hydroxide (finding) |
Causative agent (attribute) |
False |
Aluminium hydroxide |
Inferred relationship |
Some |
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium hydroxide |
Inferred relationship |
Some |
|
Dried aluminium hydroxide gel 44 mg/mL and magnesium hydroxide 39 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium hydroxide |
Inferred relationship |
Some |
|
Dried aluminium hydroxide gel 120 mg/mL and magnesium hydroxide 60 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium hydroxide |
Inferred relationship |
Some |
|
Product containing aluminium hydroxide and magnesium hydroxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Product containing aluminium hydroxide and simeticone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Aluminum hydroxide + dimethicone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium hydroxide |
Inferred relationship |
Some |
|
Aluminium hydroxide- and magnesium trisilicate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Allergy to aluminium hydroxide (finding) |
Causative agent (attribute) |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Aluminium hydroxide dried gel |
Is a |
False |
Aluminium hydroxide |
Inferred relationship |
Some |
|
Aluminium hydroxide hydrate |
Is a |
False |
Aluminium hydroxide |
Inferred relationship |
Some |
|
Aluminium hydroxide 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Aluminium hydroxide 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Product containing precisely aluminium hydroxide 475 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Product containing precisely aluminium hydroxide 475 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aluminium hydroxide |
Inferred relationship |
Some |
2 |
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Aluminium hydroxide |
Inferred relationship |
Some |
2 |
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Aluminium hydroxide hydrate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
|
Product containing aluminium hydroxide and belladonna alkaloid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Aluminium hydroxide 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Product containing precisely aluminium hydroxide 475 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Product containing aluminium hydroxide and magnesium hydroxide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Algeldrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Aluminium hydroxide |
Inferred relationship |
Some |
|
Dried aluminium hydroxide gel |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Aluminium hydroxide |
Inferred relationship |
Some |
|
Product containing aluminium hydroxide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Alginic acid and aluminium hydroxide and magnesium trisilicate and sodium bicarbonate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Aluminium hydroxide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Aluminium hydroxide and magnesium carbonate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Product containing only aluminium hydroxide and belladonna alkaloid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Aluminium hydroxide and magnesium hydroxide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Product containing only aluminium hydroxide and magnesium hydroxide and simeticone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Aluminium hydroxide and magnesium trisilicate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Product containing only aluminium hydroxide and simeticone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Aluminium hydroxide and magnesium hydroxide only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Product containing only aluminium hydroxide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Product containing only aluminium hydroxide and dimeticone and magnesium hydroxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Aluminium hydroxide and dimeticone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
2 |
Aluminium hydroxide 58.2 mg/mL and magnesium hydroxide 19.6 mg/mL and oxetacaine 2 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
2 |
Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
3 |
Product containing only aluminium hydroxide and magnesium hydroxide and oxetacaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
2 |
Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
3 |
Product containing aluminium hydroxide and magnesium hydroxide and oxetacaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
2 |
Aluminium hydroxide anhydrous (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
|
Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Aluminium hydroxide and magnesium hydroxide and simeticone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Aluminium hydroxide- and magnesium hydroxide- and simeticone-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |
Aluminium hydroxide- and dimeticone- and magnesium hydroxide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aluminium hydroxide |
Inferred relationship |
Some |
1 |